April 04, 2026
(Saturday)
The Biggest Mistake Indian Investors Make: Judging Performance by Raw Returns Alone
Imagine two mutual fund managers. Manager A delivers 25% returns in a year. Manager B delivers 20% returns. Which one is better?
If you said Manager A โ congratulations, you just made the same mistake that 95% of Indian retail investors make every single day. And this mistake is silently costing you lakhs of rupees over your investing lifetime.
Here’s why: Manager A achieved 25% returns by taking wild bets โ concentrated positions in penny stocks, leveraged F&O trades, and speculative sector calls. During the year, his portfolio swung from +45% to -20% before recovering. Manager B achieved 20% returns through disciplined stock picking of quality compounders โ his portfolio never dropped more than 8% at any point.
Who would you rather trust with your life savings? The answer is obvious โ but without risk-adjusted return metrics like the Sharpe Ratio and Sortino Ratio, you’d never know the difference. Today, we’re going to demystify these two powerful tools that professional fund managers and institutional investors use every single day โ and show you exactly how to apply them as an Indian retail investor.
Why Raw Returns Are Dangerous โ The Indian Market Context
The Indian stock market has been on a volatile ride recently. As of April 2, 2026, the Sensex closed at 73,317 while the Nifty 50 stood at approximately 22,540 โ both under pressure from Iran war tensions, crude oil spiking above $105/barrel, and sustained FII outflows of nearly โน10,000 crore in a single day. In this environment, chasing raw returns is not just misguided โ it’s financial suicide.
Consider this: SEBI’s own study found that 9 out of 10 individual traders in the equity F&O segment incurred net losses. Many of these traders were chasing massive returns through leveraged positions. Their raw return targets were 50-100% annually โ but their risk-adjusted returns were catastrophically negative because they were taking on enormous volatility and drawdown risk to achieve those targets.
This is precisely why the Sharpe Ratio and Sortino Ratio exist โ to strip away the illusion of raw returns and reveal the true quality of investment performance.
The Sharpe Ratio: Your Portfolio’s Report Card
What Is the Sharpe Ratio?
Developed by Nobel Prize-winning economist William F. Sharpe in 1966, the Sharpe Ratio measures how much excess return you earn for each unit of risk (volatility) you take. The formula is elegantly simple:
Sharpe Ratio = (Portfolio Return โ Risk-Free Rate) รท Standard Deviation of Portfolio Returns
Let’s break this down for Indian investors:
Portfolio Return: Your actual returns over the measurement period (say, 18% annually).
Risk-Free Rate: In India, this is typically the yield on 10-year Government of India bonds โ currently around 7.0-7.2%. This represents the return you could earn with virtually zero risk.
Standard Deviation: This measures how wildly your returns fluctuate. A portfolio that delivers steady 15-20% each year has low standard deviation. A portfolio that swings between -30% and +60% has high standard deviation.
How to Interpret the Sharpe Ratio
Here’s a practical guide for Indian investors:
Below 0.5: Poor risk-adjusted returns. You’re taking too much risk for the returns you’re getting. Most F&O gamblers fall in this category โ even the “profitable” ones.
0.5 to 1.0: Acceptable. You’re earning reasonable compensation for the risk taken. Many actively managed mutual funds in India fall in this range.
1.0 to 2.0: Good to excellent. This is where disciplined value investors typically land. You’re generating strong excess returns relative to the volatility you endure.
Above 2.0: Outstanding. Very few investors sustain this over 5+ years. If someone claims a Sharpe Ratio above 3.0 consistently, be skeptical โ they may be cherry-picking their measurement period or taking hidden risks.
Real-World Example: Indian Mutual Funds
Let’s compare two popular Indian equity mutual fund categories over a hypothetical 5-year period:
Small-Cap Fund: Annual return 22%, standard deviation 28%, risk-free rate 7%. Sharpe Ratio = (22 โ 7) รท 28 = 0.54
Flexi-Cap Quality Fund: Annual return 16%, standard deviation 14%, risk-free rate 7%. Sharpe Ratio = (16 โ 7) รท 14 = 0.64
See what happened? The small-cap fund delivered 6% higher raw returns, but the flexi-cap quality fund had a higher Sharpe Ratio โ meaning it delivered better risk-adjusted performance. The quality fund gave you more return per unit of sleepless nights.
The Sortino Ratio: The Sharpe Ratio’s Smarter Cousin
The Flaw in the Sharpe Ratio
The Sharpe Ratio has one significant weakness: it treats all volatility as bad. But as investors, we don’t mind upside volatility โ we love it when our stocks unexpectedly surge 30% in a quarter! What we hate is downside volatility โ when our portfolio drops 20% and we can’t sleep at night.
This is where the Sortino Ratio comes in. Developed by Frank Sortino, it refines the Sharpe Ratio by only penalizing downside deviation โ the volatility that actually hurts you.
Sortino Ratio = (Portfolio Return โ Risk-Free Rate) รท Downside Deviation
The key difference: instead of using total standard deviation (which includes both positive and negative fluctuations), the Sortino Ratio uses only the standard deviation of negative returns โ called downside deviation.
Why the Sortino Ratio Matters More for Indian Value Investors
Value investing by its very nature produces asymmetric returns. When you buy quality companies at reasonable valuations, your downside is limited (because you bought with a margin of safety), but your upside can be enormous when the market recognizes the company’s true value.
A quality stock like Titan Biotech (BSE: 524717), currently trading at โน504 with a market capitalisation of approximately โน2,082 crore and outstanding capital efficiency metrics โ ROCE of 16.9% and a debt-free balance sheet โ is a perfect example. With revenue growing consistently and strong secular demand for its culture media products across pharma and diagnostics, this is the kind of quality business that compounds wealth steadily. This kind of consistent quality generates returns with more upside volatility than downside โ exactly the profile that the Sortino Ratio rewards.
For such asymmetric return profiles, the Sharpe Ratio unfairly penalizes the stock for its upside surges. The Sortino Ratio gives you the true picture: strong returns with limited downside risk.
Sortino Ratio Benchmarks for Indian Investors
Below 1.0: Your downside risk isn’t being adequately compensated. Reassess your strategy.
1.0 to 2.0: Solid performance. Your strategy is generating good returns without excessive downside pain.
Above 2.0: Excellent. You’re capturing upside while protecting against drawdowns โ the hallmark of great value investors.
How to Calculate These Ratios for Your Own Portfolio
Step-by-Step Guide for Indian Investors
Step 1: Gather Your Monthly Returns
Export your portfolio’s monthly returns for at least 36 months (3 years) from your broker’s platform โ Zerodha Console, Groww, or Angel One all offer this. You can also calculate this manually from your CAMS/Karvy consolidated account statements.
Step 2: Calculate Your Average Monthly Return
Add all monthly returns and divide by the number of months. Then annualize by multiplying by 12.
Step 3: Find the Risk-Free Rate
Use the current 10-year Indian Government Bond yield (approximately 7.0% as of April 2026). Convert to monthly: 7.0 รท 12 = 0.583% per month.
Step 4: For Sharpe Ratio
Calculate the standard deviation of all monthly returns. Then apply the formula: (Annualized Return โ 7.0%) รท (Monthly Std Dev ร โ12).
Step 5: For Sortino Ratio
Filter only the months where your return was below the risk-free rate (0.583% monthly). Calculate the standard deviation of only these negative excess returns. Then: (Annualized Return โ 7.0%) รท (Downside Deviation ร โ12).
Many free online tools and even Excel templates exist for this calculation. Websites like Value Research Online and Morningstar India display Sharpe Ratios for mutual funds, which you can use as benchmarks.
Five Practical Applications for Indian Investors
1. Comparing Mutual Funds Beyond Star Ratings
Star ratings from Morningstar and Value Research are useful but limited. A 5-star fund with a Sharpe Ratio of 0.4 is worse than a 3-star fund with a Sharpe Ratio of 0.8. Always check the Sharpe Ratio alongside star ratings when selecting mutual funds for your SIP portfolio.
2. Evaluating Your PMS or Smallcase Performance
Portfolio Management Services (PMS) in India often advertise impressive raw returns. But many achieve those returns through concentrated bets and high turnover โ which means enormous volatility. Ask your PMS manager for the Sharpe and Sortino Ratios. If they can’t provide them or the numbers are below 0.5, you’re paying 2-3% fees for mediocre risk-adjusted performance.
3. Comparing Your Direct Stock Portfolio to Benchmarks
If you pick individual stocks like a value investor, calculate your portfolio’s Sharpe Ratio and compare it against the Nifty 50’s Sharpe Ratio over the same period. If your Sharpe Ratio is lower, you’re taking more risk than a simple index fund โ and you might be better off with passive investing until you develop sharper stock-picking skills.
4. Identifying Overrated “Star” Investors on Social Media
Indian fintwit and YouTube are full of “investors” showcasing 100%+ CAGR screenshots. Ask them: “What’s your Sharpe Ratio?” If they don’t know or won’t share it, their returns likely came with stomach-churning drawdowns that most people can’t endure. A 40% CAGR with a Sharpe of 0.3 is far worse than a 18% CAGR with a Sharpe of 1.2.
5. Building a Better Portfolio with Quality Compounders
The highest Sharpe and Sortino Ratios over long periods come from portfolios built on quality compounders โ companies with consistent earnings growth, low debt, high return ratios, and honest management. This is exactly the type of company we study at Multibagger Shares.
For a complete education on how to identify such quality compounders, watch our Free Value Investing Course on YouTube.
Common Mistakes When Using Risk-Adjusted Metrics
Mistake #1: Using Too Short a Time Period. A Sharpe Ratio calculated over 6 months is meaningless. Use at least 3 years, preferably 5+ years that include both bull and bear markets. The current market volatility from Iran tensions makes this especially important โ any metric calculated only during 2024’s bull run will look artificially inflated.
Mistake #2: Ignoring the Risk-Free Rate. Some online calculators default to a 0% risk-free rate. For Indian investors, this overstates the Sharpe Ratio significantly. Always use the current 10-year G-Sec yield.
Mistake #3: Comparing Across Different Asset Classes. Don’t compare the Sharpe Ratio of your equity portfolio to a debt fund’s Sharpe Ratio directly. These operate in fundamentally different risk-return universes.
Mistake #4: Forgetting That Past Risk-Adjusted Returns Don’t Guarantee Future Performance. A fund with a great Sharpe Ratio last year might have changed its strategy, lost its star fund manager, or the market regime might have shifted.
The Titan Biotech Connection: Quality = Better Risk-Adjusted Returns
Companies like Titan Biotech (BSE: 524717) exemplify why quality investing produces superior risk-adjusted returns over time. Trading at โน504 with a market cap of โน2,082 crore, Titan Biotech demonstrates the hallmarks of a quality compounder โ consistent revenue growth, a debt-free balance sheet, and ROCE of 16.9%. This kind of consistent quality generates returns with more upside volatility than downside โ exactly the asymmetry that produces excellent Sortino Ratios.
When a company has virtually no debt, its risk of financial distress during downturns is near zero โ this directly reduces downside deviation and improves the Sortino Ratio. When earnings grow consistently, the stock’s upward trajectory becomes more predictable โ reducing overall standard deviation and improving the Sharpe Ratio.
This is precisely why we at Multibagger Shares focus relentlessly on quality metrics: because quality doesn’t just deliver returns โ it delivers better risk-adjusted returns. And over a 10-20 year investing horizon, the compounding effect of superior risk-adjusted returns creates an almost insurmountable wealth advantage.
The Bottom Line: Stop Gambling, Start Measuring
The next time someone brags about their 50% returns in the stock market, ask them one simple question: “What’s your Sharpe Ratio?”
If they look confused, they’re a gambler who got lucky. If they can answer with a number above 1.0, they might actually know what they’re doing.
As value investors, our goal isn’t to maximize raw returns at any cost โ it’s to maximize risk-adjusted returns over the long term. The Sharpe Ratio and Sortino Ratio are the tools that help us measure whether we’re actually achieving this goal or just fooling ourselves with cherry-picked performance numbers.
Remember: in the Indian stock market, where SEBI has confirmed that 90% of F&O traders lose money, the survivors aren’t the ones who took the biggest bets. They’re the ones who managed risk the best. And risk-adjusted return metrics are how you keep score.
Invest wisely. Invest in quality. And always measure what truly matters.
โ Manish Goel
Founder, Multibagger Shares | SEBI Registered Research Analyst
SEBI Disclaimer: 9 out of 10 individual traders in the equity Futures & Options segment incurred net losses according to a SEBI study. F&O trading is essentially gambling. Focus on quality stock picking and long-term value investing instead.
Disclaimer: The author (Manish Goel) is a SEBI Registered Research Analyst (Registration No. INH100004775) and Multibagger Shares (Multibagger Securities Research & Advisory Pvt. Ltd.) is a SEBI Registered Investment Advisor (Registration No. INA100007736). This post is for educational purposes only and should not be construed as a buy/sell recommendation. Please do your own research and consult a qualified financial advisor before making investment decisions. Stock market investments are subject to market risks. Past performance is not indicative of future results.
๐ข Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates โ delivered straight to your phone!
โ๏ธ Join @longtermequityy on Telegram
๐ Free โข No spam โข Value investing insights daily